Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sanofi (SNY)
NASDAQ:SNY
Holding SNY?
Track your performance easily
SNY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$44.05 - $58.97
Previous Close$54.34
Volume3.25M
Average Volume (3M)1.76M
Market Cap
$136.26B
Enterprise Value$146.01B
Total Cash (Recent Filing)€8.71B
Total Debt (Recent Filing)€18.15B
Price to Earnings (P/E)29.8
Beta0.34
Next Earnings
Jan 30, 2025EPS Estimate
$0.93Last Dividend Ex-Date
May 09, 2024Dividend Yield2.72%
Share Statistics
EPS (TTM)1.82
Shares Outstanding2,529,599,938
10 Day Avg. Volume2,077,558
30 Day Avg. Volume1,763,845
Standard Deviation0.06
R-Squared0.26
Alpha0.00120
Financial Highlights & Ratios
Price to Book (P/B)1.86
Price to Sales (P/S)2.66
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$65.00Price Target Upside19.62% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Sanofi News
Bulls Say, Bears Say
Bulls Say
Financial StabilityHealthy balance sheet with strong operating cash flow.
Market LeadershipSanofi is the leader in global generic drugs industry, especially in chemical generic drugs.
Revenue GrowthDupixent indication expansion will continue to drive revenues moving forward.
Bears Say
Clinical Trial ResultsIn CPUO, the first Phase 3 trial failed to achieve statistical significance on the primary itch responder endpoint.
EarningsBoth 3Q23 revenue and earnings missed expectations.
Regulatory ChallengesAn initial U.S. filing for CSU received a CRL from FDA requesting additional efficacy data.
---
Ownership Overview
―
Insiders
3.78% Mutual Funds
0.19% Other Institutional Investors
95.81% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SNY FAQ
What was Sanofi’s price range in the past 12 months?
Sanofi lowest stock price was $44.05 and its highest was $58.97 in the past 12 months.
What is Sanofi’s market cap?
Currently, no data Available
When is Sanofi’s upcoming earnings report date?
Sanofi’s upcoming earnings report date is Jan 30, 2025 which is in 83 days.
How were Sanofi’s earnings last quarter?
Sanofi released its earnings results on Oct 25, 2024. The company reported $1.549 earnings per share for the quarter, beating the consensus estimate of $1.354 by $0.195.
Is Sanofi overvalued?
According to Wall Street analysts Sanofi’s price is currently Undervalued.
Does Sanofi pay dividends?
Sanofi pays a Annually dividend of $1.48 which represents an annual dividend yield of 2.72%. See more information on Sanofi dividends here
What is Sanofi’s EPS estimate?
Sanofi’s EPS estimate is $0.93.
How many shares outstanding does Sanofi have?
Sanofi has 2,537,828,600 shares outstanding.
What happened to Sanofi’s price movement after its last earnings report?
Sanofi reported an EPS of $1.549 in its last earnings report, beating expectations of $1.354. Following the earnings report the stock price went up 4.4%.
Which hedge fund is a major shareholder of Sanofi?
Among the largest hedge funds holding Sanofi’s share is Dodge & Cox. It holds Sanofi’s shares valued at 4B.
---
Sanofi Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$65.00 (19.62% Upside)
$65.00 (19.62% Upside)
Blogger Sentiment
Bullish
SNY Sentiment 92%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 990.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.5%
Last 30 Days ▲ 7.0%
Last 30 Days ▲ 7.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.46%
12-Months-Change
Fundamentals
Return on Equity
5.80%
Trailing 12-Months
Asset Growth
1.69%
Trailing 12-Months
Company Description
Sanofi
Founded in 1973, Sanofi is a France-based leading global healthcare company, which provides therapeutic solutions worldwide. It operates through business units including Pharmaceuticals (comprised of General Medicines and Speciality Care), Consumer Healthcare, and Vaccines.
---
SNY Company Deck
---
SNY Earnings Call
Q3 2024
0:00 / 0:00
---
SNY Stock 12 Month Forecast
Average Price Target
$65.00
▲(19.62% Upside)
Technical Analysis
Best Analysts Covering SNY
1 Year
1 Year Success Rate
5/7 ratings generated profit
1 Year Average Return
+2.26%
reiterated a buy rating 22 days ago
Copying Luisa Hector's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +2.26% per trade.
---